Hyperzincaemia and hypercalprotectinaemia: A new disorder of zinc metabolism

Lancet

Volumn 360, Issue 9347, 2002, Pages 1742-1745

  Sampson, Barry ^a   Fagerhol, Magne K ^b   Sunderkötter, Cord ^c   Golden, Barbara E ^d   Richmond, Peter ^e   Klein, Nigel ^e   Kovar, Ilya Z ^f   Beattie, John H ^g   Wolska Kusnierz, Beata ^h   Saito, Yoshiaki ⁱ   Roth, Johannes ^c  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^g ROWETT RESEARCH INSTITUTE   (United Kingdom)

^h CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

ⁱ TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CALPROTECTIN; PROTEIN SUBUNIT;

ADOLESCENT; ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HYPERCALPROTECTINAEMIA; HYPERZINCAEMIA; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLIC DISORDER; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FAMILY; PROTEIN PURIFICATION; SCHOOL CHILD; ZINC METABOLISM;

EID: 0037202853     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11683-7     Document Type: Article

References (32)

1. Danks D.M. Inborn errors of trace element metabolism. Clin Endocrinol Metab. 14:1985;591-615.
2. Smith J.C. Jr, Zeller J.A., Brown E.D., Ong S.G. Elevated plasma zinc. A heritable anomaly. Science. 193:1983;496-498.
3. Failla M.L., van der Veerdonk M., Morgan W.T., Smith J.C. Characterization of zinc binding proteins of plasma in familial hyperzincemia. J Lab Clin Med. 100:1982;943-952.
4. Hambidge K.M., Norris D.A., Githens J.H., Ambruso D., Catalanotto F.A. Hyperzincaemia in a patient with pyoderma gangrenosum. J Pediatr. 106:1985;450-451.
5. Sampson B., Kovar I.Z., Rauscher A., et al. A case of hyperzincaemia with functional zinc depletion: a new disorder? Pediatr Res. 42:1997;219-225.
6. Richmond P., Sampson B., Golden B., Fagerhol M., Kovar I., Klein N. Dysregulation of calprotectin metabolism is associated with a multi-system autoimmune vasculitis. Arch Dis Child. 80:(suppl):1999;67A.
7. Johne B., Fagerhol M.K., Lyberg T., et al. Functional and clinical aspects of the myeolomonocyte protein calprotectin. Mol Path. 50:1997;113-123.
8. Hessian P.A., Edgeworth J., Hogg N. MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J Leukoc Biol. 53:1993;197-204.
9. Sorg C. The calcium binding proteins MRP8 and MRP14 in acute and chronic inflammation. Behring Inst Mitt. 91:1992;126-137.
10. Steinbakk M., Naess-Andresen C.-F., Lingaas E., Dale I., Brandtzaeg P., Fagerhol M.K. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet. 336:1990;763-765.
11. 2 integrin Mac-1 on neutrophils. J Immunol. 160:1998;1427-1435.
12. Saito Y., Saito K., Hirano Y., et al. Hyperzincemia with systemic inflammation: a heritable disorder of calprotectin metabolism with rheumatic manifestation? J Pediatr. 140:2002;267-269.
13. Rammes A., Roth J., Goebeler M., Klempt M., Hartmann M., Sorg C. Myeloid related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem. 272:1997;9496-9502.
14. Roth J., Burwinkel F., van den Bos C., Goebeler M., Vollmer E., Sorg C. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood. 82:1993;1875-1883.
15. Roseth A.G., Fagerhol M.K., Aadland E., Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in feces: a methodological study. Scand J Gastroenterol. 27:1992;793-798.
16. Vogl T., Roth J., Sorg C., Hillenkamp F., Strupat K. Calcium- induced noncovalently linked tetramers of MRP8 and MRP14 detected by ultraviolet matrix-assisted laser desorption/ ionization mass spectrometry. J Am Soc Mass Spectrom. 10:1999;1124-1130.
17. Lagasse E., Clerc R.G. Cloning and expression of two human genes encoding calcium binding proteins that are regulated during myeloid differentiation. Mol Cell Biol. 8:1988;2402-2410.
18. Brandtzaeg P., Dale I., Fagerhol M.K. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. Am J Clin Pathol. 87:1987;700-707.
19. Eversole L.R., Miyasaki K.T., Christensen R.E. The distribution of the antimicrobial protein, calprotectin, in normal oral keratinocytes. Arch Oral Biol. 37:1992;963-968.
20. Myers M., Fleck A., Sampson B., Colley C.M., Bent J., Hall G. Early serum protein and mineral changes after surgery: a two stage process. J Clin Pathol. 37:1984;862-866.
21. Schafer B.W., Heizmann C.W. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci. 21:1996;134-140.
22. Clohessy P.A., Golden B.E. His-X-X-X-His motifs in S100 protein, calprotectin: relation to microbiostatic activity. J Leukoc Biol. 60:1996;674.
23. Loomans H.J., Hahn B.L., Li Q.Q., Phadnis S.H., Sohnle P.G. Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin. J Infect Dis. 177:1998;812-814.
24. Jongeel C.V., Bouvier J., Bairoch A. A unique signature identifies a family of zinc dependent metallopeptidases. FEBS Lett. 242:1989;211-214.
25. Yui S., Mikami M., Yamazaki M. Purification and characterization of the cytotoxic factor in rat peritoneal-exudate cells: its identification as the calcium-binding protein complex, calprotectin. J Leukoc Biol. 58:1995;307-316.
26. Sohnle P.G. Antimicrobial defence through competition for zinc. Rev Med Microbiol. 8:1997;217-224.
27. Prasad A.S., Brewer G.J., Schoomaker E.B., Rabbani P. Hypocupremia induced by zinc therapy in adults. JAMA. 240:1978;2166-2168.
28. Chandra R.K. Excessive intake of zinc impairs immune response. JAMA. 252:1984;1443-1446.
29. Unoshima M., Nishizono A., Takita-Sonoda Y., Iwasaka H., Noguchi T.S.O. Effects of zinc acetate on splenocytes of endotoxemic mice: enhanced immune response, reduced apoptosis, and increased expression of heat shock protein 70. J Lab Clin Med. 137:2001;28-37.
30. Neves I., Bertho A.L., Veloso V.G., Nascimento D.V., Campos-Mello D.L., Morgado M.G. Improvement of the lymphoproliferative immune response and apoptosis inhibition upon in vitro treatment with zinc of peripheral blood mononuclear cells (PBMC) from HIV+ individuals. Clin Exp Immunol. 111:1998;264-268.
31. Mikami M., Yamazaki M., Yui S. Kinetical analysis of tumour cell death-inducing mechanism by polymorphonuclear leukocyte-derived calprotectin: involvement of protein synthesis and generation of reactive oxygen species in target cells. Microbiol Immunol. 42:1998;211-221.
32. Srikrishna G., Panneerselvam K., Westphal V., Abraham V., Varki A., Freeze H.-H. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J Immunol. 166:2001;4678-4688.